Booth Andrew (CIK 1834411) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Buy ABCL (250,000 shares), Buy ABCL (42,600 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | AbCellera Biologics Inc. (ABCL) | Chief Financial Officer | Buy | 250,000 | $47,500 |
| 2026-02-27 | AbCellera Biologics Inc. (ABCL) | Chief Financial Officer | Buy | 42,600 | $145,692 |
Source: SEC Form 4 filings · as of 2026-06-03